Investing Profile

Dominik Escher

VCInvestor
Managing Partner at Pureos Bioventures
pureosbio.comZurich, Switzerland
Photo of Dominik Escher, Managing Partner at Pureos Bioventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Eidgenössische Technische Hochschule Zürich Network
38 CONNECTIONS
ETH Zürich Network
31 CONNECTIONS
Universität Zürich | University of Zurich Network
13 CONNECTIONS
Universität Zürich | University of Zurich Network
13 CONNECTIONS
cb
Pureos Bioventures Managing Partner
$100K - $5.0M
$1.5M
6
$205M
CompanyStageDateRound SizeTotal Raised
Tavo Biotherapeutics
Series AJun 2026$17M
$17M
PulseSight Therapeutics
Series AFeb 2025
SeedFeb 2024
Araris Biotech
Series AOct 2022$24M
$24M
Co-investors: Dima Kuzmin (4BIO Capital)
Engimmune Therapeutics
SeedMay 2022$16M
$16M
Eyevensys
Series BJan 2020$30M
$30M
Chairman CDR-Life Inc.Present
Board Member Topadur Pharma AGPresent
Board of Directors NovaGo TherapeuticsPresent
Board Member EyevensysPresent
Board Member Araris Biotech AGPresent
Honorary Member Swiss Biotech AssociationPresent
Chairman of the Board of Trustees Botnar Institute of Immune Engineering – BIIEPresent
CEO ESBATech, a Novartis companyPresent
Managing Partner Pureos BioventuresPresent
Eidgenössische Technische Hochschule Zürich Master Education
ETH Zürich Master Education
Universität Zürich | University of Zurich M.S. Molecular Biology, Immunology, Biochemistry
Universität Zürich | University of Zurich Ph.D., Molecular Biology Molecular Biology